Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 18579287)

  • 1. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
    Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
    Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
    Moore BB; Arenberg DA; Stoy K; Morgan T; Addison CL; Morris SB; Glass M; Wilke C; Xue YY; Sitterding S; Kunkel SL; Burdick MD; Strieter RM
    Am J Pathol; 1999 May; 154(5):1503-12. PubMed ID: 10329603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfotyrosine recognition as marker for druggable sites in the extracellular space.
    Ziarek JJ; Heroux MS; Veldkamp CT; Peterson FC; Volkman BF
    Int J Mol Sci; 2011; 12(6):3740-56. PubMed ID: 21747703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets.
    Wang J; Ouyang X; Zhu W; Yi Q; Zhong J
    Cancer Control; 2024; 31():10732748241241162. PubMed ID: 38533911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
    Bao Y; Tong C; Xiong X
    Life Sci; 2024 Jul; 348():122691. PubMed ID: 38714265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12-3' A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?
    Coelho A; Calçada C; Catarino R; Pinto D; Fonseca G; Medeiros R
    Cancer Immunol Immunother; 2006 Jun; 55(6):639-43. PubMed ID: 16155757
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2011 Feb; 22(1):1-18. PubMed ID: 21111666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.
    Mukaida N; Sasaki S; Baba T
    Mediators Inflamm; 2014; 2014():170381. PubMed ID: 24966464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CXCL1 paracrine network links cancer chemoresistance and metastasis.
    Acharyya S; Oskarsson T; Vanharanta S; Malladi S; Kim J; Morris PG; Manova-Todorova K; Leversha M; Hogg N; Seshan VE; Norton L; Brogi E; Massagué J
    Cell; 2012 Jul; 150(1):165-78. PubMed ID: 22770218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of the CXC ligand family in the pancreatic tumor microenvironment.
    Lee NH; Nikfarjam M; He H
    Pancreatology; 2018 Oct; 18(7):705-716. PubMed ID: 30078614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.
    Li BH; Garstka MA; Li ZF
    Mol Immunol; 2020 Jan; 117():201-215. PubMed ID: 31835202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.